{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:47:17Z","timestamp":1792010837461,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022A1515010636"],"award-info":[{"award-number":["2022A1515010636"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A03J0206"],"award-info":[{"award-number":["2023A03J0206"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771442"],"award-info":[{"award-number":["81771442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.schres.2026.09.031","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:23:25Z","timestamp":1790069005000},"page":"619-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Interleukin-17 potentially links prolactin to positive symptoms in first-episode drug-naive schizophrenia: An exploratory cross-sectional study"],"prefix":"10.1016","volume":"297","author":[{"given":"Wenxi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2026.09.031_bb0005","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.schres.2026.09.031_bb0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cellimm.2012.01.001","article-title":"Aging is associated with circulating cytokine dysregulation","volume":"273","author":"Alvarez-Rodriguez","year":"2012","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.schres.2026.09.031_bb0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.schres.2026.09.031_bb0020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.pnpbp.2010.02.019","article-title":"Hyperprolactinaemia in early psychosis-not only due to antipsychotics","volume":"34","author":"Aston","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.031_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2023.106049","article-title":"Prolactin and morning cortisol concentrations in antipsychotic na\u00efve first episode psychosis: a systematic review and meta-analysis","volume":"150","author":"Aymerich","year":"2023","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.schres.2026.09.031_bb0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1212\/WNL.0000000000002252","article-title":"Cognitive functioning of patients with a PRL-secreting pituitary adenoma: a preliminary report","volume":"86","author":"Bala","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.schres.2026.09.031_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101324","article-title":"Prolactin and autoimmunity: the hormone as an inflammatory cytokine","volume":"33","author":"Borba","year":"2019","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.schres.2026.09.031_bb0040","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jpsychires.2012.08.016","article-title":"Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse","volume":"46","author":"Borovcanin","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.schres.2026.09.031_bb0045","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ajpath.2013.01.005","article-title":"Regulation of IL-17 family members by adrenal hormones during experimental sepsis in mice","volume":"182","author":"Bosmann","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.schres.2026.09.031_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0972753120929565","article-title":"Interleukin-17 and interleukin-10 association with disease progression in schizophrenia","volume":"27","author":"Chenniappan","year":"2020","journal-title":"Ann. Neurosci."},{"issue":"12","key":"10.1016\/j.schres.2026.09.031_bb0055","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.5498\/wjp.v14.i12.1804","article-title":"Interaction between serum inflammatory cytokines and brain-derived neurotrophic factor in cognitive function among first-episode schizophrenia patients","volume":"14","author":"Cui","year":"2024","journal-title":"World J. Psychiatry"},{"issue":"17","key":"10.1016\/j.schres.2026.09.031_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173849","article-title":"The role of cytokines in the pathogenesis of schizophrenia","volume":"10","author":"Dawidowski","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.schres.2026.09.031_bb0065","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/schbul\/sbu049","article-title":"Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications","volume":"40","author":"Debnath","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"1\u20133","key":"10.1016\/j.schres.2026.09.031_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2013.10.019","article-title":"Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway","volume":"151","author":"Dimitrov","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.031_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pnpbp.2014.01.001","article-title":"Activation of Th17 cells in drug naive, first episode schizophrenia","volume":"51","author":"Ding","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.031_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.880568","article-title":"Immune system abnormalities in schizophrenia: an integrative view and translational perspectives","volume":"13","author":"Ermakov","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.09.031_bb0085","first-page":"135","article-title":"Interleukin-17 alteration in first-episode psychosis: a meta-analysis","volume":"3","author":"Fang","year":"2018","journal-title":"Mol. Neuropsychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.09.031_bb0090","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-023-01976-6","article-title":"The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis","volume":"28","author":"Gigase","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.09.031_bb0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2022.11.003","article-title":"Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology","volume":"93","author":"Goldsmith","year":"2023","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2026.09.031_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4530(02)00112-9","article-title":"Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.schres.2026.09.031_bb0105","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17\u2013producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.schres.2026.09.031_bb0110","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/jdv.12295","article-title":"Prolactin induces the production of Th17 and Th1 cytokines\/chemokines in murine Imiquimod-induced psoriasiform skin","volume":"28","author":"Hau","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.schres.2026.09.031_bb0115","series-title":"Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach","author":"Hayes","year":"2013"},{"issue":"8","key":"10.1016\/j.schres.2026.09.031_bb0120","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/ijnp\/pyac023","article-title":"The influence of oxytocin and prolactin during a first episode of psychosis: the implication of sex differences, clinical features, and cognitive performance","volume":"25","author":"Hidalgo-Figueroa","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2026.09.031_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.278","article-title":"Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization","volume":"7","author":"Howes","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.09.031_bb0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cns.13569","article-title":"Peripheral inflammation and blood\u2013brain barrier disruption: effects and mechanisms","volume":"27","author":"Huang","year":"2021","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.schres.2026.09.031_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.67","article-title":"Schizophrenia","volume":"1","author":"Kahn","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.schres.2026.09.031_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.486811","article-title":"Hippocampal hyperactivity as a druggable circuit-level origin of aberrant salience in schizophrenia","volume":"11","author":"K\u00e4tzel","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.schres.2026.09.031_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2026.09.031_bb0150","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.09.031_bb0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psyneuen.2018.11.028","article-title":"The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders","volume":"102","author":"Labad","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.schres.2026.09.031_bb0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ni.1969","article-title":"T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding ROR\u03b3t","volume":"12","author":"Lazarevic","year":"2011","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.schres.2026.09.031_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.284","article-title":"Critical role of astrocytic interleukin-17A in post-stroke survival and neuronal differentiation of neural precursor cells in adult mice","volume":"7","author":"Lin","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.schres.2026.09.031_bb0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s12888-021-03569-5","article-title":"Relationship between TNF-alpha levels and psychiatric symptoms in first-episode drug-naive patients with schizophrenia before and after risperidone treatment and in chronic patients","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.09.031_bb0175","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3758\/s13428-020-01407-2","article-title":"t-Test and ANOVA for data with ceiling and\/or floor effects","volume":"53","author":"Liu","year":"2021","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.schres.2026.09.031_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/srep07554","article-title":"Interleukin-17 inhibits adult hippocampal neurogenesis","volume":"4","author":"Liu","year":"2014","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.schres.2026.09.031_bb0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00702-024-02748-4","article-title":"The relationship between serum prolactin levels and cognitive function in drug-naive schizophrenia patients: a cross-sectional study","volume":"131","author":"Luo","year":"2024","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.schres.2026.09.031_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.schres.2026.09.031_bb0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1043-4666(02)00496-9","article-title":"Prolactin enhances production of interferon-gamma, interleukin-12, and interleukin-10, but not of tumor necrosis factor-alpha, in a stimulus-specific manner","volume":"21","author":"Matalka","year":"2003","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.schres.2026.09.031_bb0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1365-2567.1999.00893.x","article-title":"Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells","volume":"98","author":"Matera","year":"1999","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.schres.2026.09.031_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/life12121972","article-title":"Cytokines as potential biomarkers of clinical characteristics of schizophrenia","volume":"12","author":"Mednova","year":"2022","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.schres.2026.09.031_bb0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","article-title":"Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond","volume":"132","author":"Meyer","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.schres.2026.09.031_bb0215","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2021.07.008","article-title":"Neural circuit function redundancy in brain disorders","volume":"70","author":"Mizusaki","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.schres.2026.09.031_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.09.031_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089428","article-title":"Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis","volume":"9","author":"Montalvo","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.schres.2026.09.031_bb0230","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"Muller","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2026.09.031_bb0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tem.2010.01.005","article-title":"Metabolic and stress-related roles of prolactin-releasing peptide","volume":"21","author":"Onaka","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.schres.2026.09.031_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1072380","article-title":"IL-17 and TNF-\u03b2: predictive biomarkers for transition to psychosis in ultra-high risk individuals","volume":"13","author":"Ouyang","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.09.031_bb0245","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12888-025-06629-2","article-title":"Mediation by elevated prolactin in the relationship between childhood trauma and first-episode drug-naive schizophrenia","volume":"25","author":"Pan","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.09.031_bb0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/13651501.2016.1197274","article-title":"Prolactin levels in drug-naive patients with schizophrenia and other psychotic disorders","volume":"20","author":"Petrikis","year":"2016","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"5","key":"10.1016\/j.schres.2026.09.031_bb0255","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/schbul\/sby160","article-title":"A Meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis","volume":"45","author":"Pillinger","year":"2019","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2026.09.031_bb0260","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1515\/revneuro-2020-0082","article-title":"The role of prolactin in central nervous system inflammation","volume":"32","author":"Ramos-Martinez","year":"2021","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.schres.2026.09.031_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.536257","article-title":"Cytokine imbalance in schizophrenia. From research to clinic: potential implications for treatment","volume":"12","author":"Reale","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"40","key":"10.1016\/j.schres.2026.09.031_bb0270","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay5199","article-title":"Meningeal \u03b3\u03b4 T cell-derived IL-17 controls synaptic plasticity and short-term memory","volume":"4","author":"Ribeiro","year":"2019","journal-title":"Sci. Immunol."},{"issue":"6","key":"10.1016\/j.schres.2026.09.031_bb0275","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00406-023-01569-y","article-title":"Cytokine alterations in CSF and serum samples of patients with a first episode of schizophrenia: results and methodological considerations","volume":"273","author":"Singh","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.schres.2026.09.031_bb0280","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3109\/15622975.2014.922699","article-title":"Prolactin serum levels correlate with inflammatory status in drug-naive first-episode schizophrenia","volume":"15","author":"Song","year":"2014","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.031_bb0285","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpsychires.2020.06.014","article-title":"Relation between self-perceived stress, psychopathological symptoms and the stress hormone prolactin in emerging psychosis","volume":"136","author":"Studerus","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.09.031_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2023.11.015","article-title":"The schizophrenia syndrome, circa 2024: what we know and how that informs its nature","volume":"264","author":"Tandon","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.031_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2016.00025","article-title":"Actions of prolactin in the brain: from physiological adaptations to stress and neurogenesis to psychopathology","volume":"7","author":"Torner","year":"2016","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.schres.2026.09.031_bb0300","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.4049\/jimmunol.1001343","article-title":"STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and independent mechanisms","volume":"185","author":"Villarino","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.schres.2026.09.031_bb0305","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","article-title":"The role of IL-17 in CNS diseases","volume":"129","author":"Waisman","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.schres.2026.09.031_bb0310","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.psychres.2016.02.042","article-title":"Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population","volume":"238","author":"Wu","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.09.031_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2026.106564","article-title":"Interleukin-17 plays a crucial role in atopic dermatitis-associated blood-brain barrier disruption and cognitive impairment","volume":"136","author":"Zhang","year":"2026","journal-title":"Brain Behav. Immun."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:10:40Z","timestamp":1792008640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426003257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":63,"alternative-id":["S0920996426003257"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.09.031","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-17 potentially links prolactin to positive symptoms in first-episode drug-naive schizophrenia: An exploratory cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}